Request Deal Involvement

Permira completed the acquisition of Kedrion and Bio Products Laboratory in a $2.7bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Bank of America

financial advisors

Bank of America

Goodwin Procter

legal advisors

Goodwin Procter

Maisto e Associati

legal advisors

Maisto e Associati

Alvarez & Marsal

financial advisors

Alvarez & Marsal

FGS Global

pr advisors

FGS Global

Ernst & Young

financial advisors

Ernst & Young

Giliberti Triscornia e Associati

legal advisors

Giliberti Triscornia e Associati

Morgan Stanley

financial advisors

Morgan Stanley

Latham & Watkins

legal advisors

Latham & Watkins

Jamieson

financial advisors

Jamieson

Lazard

financial advisors

Lazard

Carnelutti Studio Legale Associato

legal advisors

Carnelutti Studio Legale Associato

Natixis Partners

financial advisors

Natixis Partners

Pedersoli Studio Legale

legal advisors

Pedersoli Studio Legale

Terzi&Partners

financial advisors

Terzi&Partners

Carnelutti Studio Legale Associato

legal advisors

Carnelutti Studio Legale Associato

Community Group

pr advisors

Community Group

or

Principals

BIO PRODUCTS LABORATORY

target

BIO PRODUCTS LABORATORY

PERMIRA FUNDS

bidder

PERMIRA FUNDS

KEDRION SPA

target

KEDRION SPA

ABU DHABI INVESTMENT AUTHORITY (ADIA)

bidder

ABU DHABI INVESTMENT AUTHORITY (ADIA)

AMPERSAND CAPITAL PARTNERS

bidder

AMPERSAND CAPITAL PARTNERS

MARCUCCI FAMILY

bidder

MARCUCCI FAMILY

FSI GLOBAL

vendor

FSI GLOBAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Permira completed the acquisition of Kedrion and Bio Products Laboratory in a $2.7bn deal.